揿针联合麻仁丸治疗糖尿病合并便秘临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R246.1;R256.35

基金项目:

无锡市卫生健康委科研项目(MS201942)


Clinical Study on Thumbtack Needle Combined with Maren Pills for Diabetes Mellitus Complicated with Constipation
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察揿针联合麻仁丸治疗糖尿病合并便秘的临床疗效。方法:选取64 例糖尿病合并便秘患 者,采用随机数字表法分为对照组和观察组各32 例,研究过程中2 组各脱落2 例。2 组均给予常规护理和治 疗,对照组在此基础上给予麻仁丸治疗,观察组在对照组基础上给予揿针治疗,2 组均治疗4 周,随访2 周。 比较2 组临床疗效、首次排便时间、排便次数和复发率,比较2 组治疗前后空腹血糖(FBG)、餐后2 h 血 糖(P2hBG)、果糖胺水平,以及便秘症状、便秘患者生活质量量表(PAC-QOL)、Kolcaba 的舒适状况量 表(GCQ)、幸福感指数量表(WHO-5) 评分,记录2 组不良反应。结果:观察组总有效率93.33%,高于对 照组73.33%(P<0.05)。观察组首次排便时间短于对照组(P<0.05)。治疗期间,观察组排便次数多于对照 组(P<0.05)。治疗后,2 组果糖胺、FBG 水平,以及对照组P2hBG 水平与同组治疗前比较,差异均无统计学 意义(P>0.05);观察组P2hBG 水平较治疗前降低,且低于对照组(P<0.05)。治疗后,2 组便秘症状、 PAC-QOL 评分均较治疗前降低(P<0.05),GCQ、WHO-5 评分均较治疗前升高(P<0.05);观察组便秘症 状、PAC-QOL 评分均低于对照组(P<0.05),GCQ、WHO-5 评分均高于对照组(P<0.05)。随访2 周,观察 组复发率10.71%,低于对照组的36.36%(P<0.05)。治疗期间,2 组均未出现明显不良反应。结论:与单纯 采用麻仁丸治疗相比,揿针联合麻仁丸治疗糖尿病合并便秘能更好地改善患者的便秘症状,提高其生活质量及 幸福感指数,且复发率低。

    Abstract:

    follow up for 2 weeks. The clinical effects,the first defecation time,the frequency of defecation and the recurrence rate in the two groups were compared; the levels of fasting blood glucose(FBG), 2- hour postprandial blood glucose(P2hBG) and fructosamine as well as the scores of constipation symptoms, Patient Assessment of Constipation Quality of Life(PAC- QOL),Kolcaba's General Comfort Questionnaire (GCQ) and WHO- 5 Well- Being Index(WHO- 5) before and after treatment in the two groups were compared;the adverse reactions in the two groups were recorded. Results:The total effective rate was 93.33% in the observation group, higher than that of 73.33% in the control group(P<0.05). The first defecation time in the observation group was shorter than that in the control group(P<0.05). During the treatment,the frequency of defecation in the observation group was higher than that in the control group (P<0.05). After treatment,there was no significant difference being found in the comparison of the levels of fructosamine and FBG between the two groups;before and after treatment,there was no significant difference being found in the comparison of the levels of P2hBG in the control group(P>0.05);the level of P2hBG in the observation group was decreased when compared with that before treatment,and was lower than that in the control group(P<0.05). After treatment, the scores of constipation symptoms and PACQOL in the two groups were decreased when compared with those before treatment(P<0.05), and the scores of GCQ and WHO-5 were increased(P<0.05). The scores of constipation symptoms and PAC-QOL in the observation group were lower than those in the control group(P<0.05),and the scores of GCQ and WHO-5 were higher(P<0.05). After 2-week follow-up,the recurrence rate was 10.71% in the observation group, lower than that of 36.36% in the control group(P<0.05). During the treatment, there was no obvious adverse reaction in the two groups. Conclusion:When compared with simple treatment of Maren Pills, the therapy of thumbtack needle combined with Maren Pills for diabetes mellitus complicated with constipation can better improve the constipation symptoms of patients,and enhance their quality of life and indexes of well-being,with a low recurrence rate.

    参考文献
    相似文献
    引证文献
引用本文

朱立萍,林嘉鳞,何珂,瞿秋燕,陆晶晶.揿针联合麻仁丸治疗糖尿病合并便秘临床研究[J].新中医,2023,55(2):152-156

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-01-29
  • 出版日期: